Antonio Magnano - Publications

Efficacy of 1 L polyethylene glycol plus ascorbate versus 4 L polyethylene glycol in split-dose for colonoscopy cleansing in out and inpatient: A multicentre, randomized trial (OVER 2019).

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 04, 2023

Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.

Journal: Inflammatory bowel diseases

Published: November 26, 2021

Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: August 14, 2021

SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501.

Journal: Journal of gastroenterology and hepatology

Published: February 05, 2021

Ustekinumab in Crohn's disease: Real-world outcomes from the Sicilian network for inflammatory bowel diseases.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: January 08, 2021

Effectiveness of Ustekinumab on Crohn's Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD).

Journal: Expert opinion on biological therapy

Published: September 28, 2020

A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 27, 2020